Increasing spending on pharmaceutical R&D, rising food safety concerns, technological advancements in analytical instruments, and the availability of funding for life science research. The growing proteomics market, rising environmental safety concerns, increasing demand for analytical instruments from various industries, and huge demand in emerging nations for life science instruments offer high growth opportunities for market players.
The global life science instrumentation market is expected to reach USD 75.24 billion by 2022 from USD 54.49 billion in 2017, at a CAGR of 6.7%.
By technology, spectroscopy segment accounted for the largest share of the life science instrumentation market.
Based on the type of technology used in the life science industry, the global life science instrumentation market has been segmented into fourteen major categories. The report covers the following analytical technologies in the life science instrumentation market—cell counting, centrifuges, chromatography, clinical chemistry analyzers, electrophoresis, flow cytometry, immunoassays, liquid handling, lyophilization, microscopy, next-generation sequencing (NGS), PCR, spectroscopy, and other technologies (including heat sterilization, colorimeter, fume hoods, incubators, laboratory balances, laboratory freezers, microplate systems, pH meters, conductivity and resistivity meters, dissolved CO2 and O2 meters, titrators, gas analyzers, TOC analyzers, thermal analyzers, and standalone robots).
The spectroscopy segment is estimated to command the largest share of the global life science instrumentation market in 2017. This can be attributed to the widespread application of spectroscopy systems across several industries, including pharmaceutical, biopharmaceutical, food and agriculture, environmental testing, and industrial chemistry.
Download PDF Brochure @
Research application segment dominated the life science instrumentation market in 2017.
Based on application, the life science instrumentation market is segmented into research applications, clinical and diagnostic applications, and other applications. In 2017, the research applications segment is estimated to command the largest share of the global life science instrumentation market. The large share of this segment is majorly attributed to the launch of technologically advanced life science instruments for the drug discovery process, increasing research activities, growth in the number of preclinical and clinical trials, and increasing adoption of high-throughput life science instruments in drug development and drug discovery.
Pharmaceutical, biopharmaceutical, and biotechnology companies segment accounted for the largest share of the life science instrumentation market, by end user.
Each analytical technology is further segmented by its end users. The major end users of this market include pharmaceutical, biopharmaceutical, and biotechnology companies; CROs; research institutions; hospitals, clinics, and diagnostic laboratories; academic institutions; forensic science laboratories; food and agriculture industry; and environmental testing industry.
Pharmaceutical, biopharmaceutical, and biotechnology companies are estimated to account for the largest share of the life science instrumentation market. Rising food and environmental safety concerns, availability of research funding for academic institutions, increasing number of criminal cases, growing number of drug discovery and development related research studies, and rising prevalence of target diseases and testing procedures related to them are pushing the demand for these analytical instruments among end users.
North America accounted for the largest share of the life science instrumentation market in 2018.
This report covers the life science instrumentation market across four major geographies, namely, North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW). North America is expected to account for the largest share of the global life science instrumentation market in 2017, followed by Europe. The large share in the North American region is mainly attributed to the large number of ongoing research activities, the presence of a large customer base, and availability of funds for drug discovery processes and life science research studies in the region.
Europe is estimated to command the second-largest share of the global market. The presence of a large number of API manufacturing facilitates, growing research on biosimilars, public-private financial investments for the development of analytical instruments, and the developing pharmaceutical sector in Russia are some of the key factors driving the growth of the life science instrumentation market in Europe.
Request for Sample Pages @
Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Agilent Technologies, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bruker Corporation (US), PerkinElmer, Inc. (US), Waters Corporation (US), Shimadzu Corporation (Japan), Illumina, Inc. (US), Siemens AG (Germany), Horiba Ltd. (Japan), Bio-Rad Laboratories, Inc. (US), Abbott Laboratories (US), Becton, Dickinson and Company (US), Hitachi High-Technologies Corporation (Japan), Eppendorf AG (Germany), QIAGEN N.V. (Netherlands), Carl Zeiss AG (Germany), Tecan Group Ltd. (Switzerland), GE Healthcare (US), and Merck KGaA (Germany) are some major players in the global life science instrumentation market.